abstract |
The present invention relates to new substituted prolinamides of general formula (I) n n n n n n n n n n wherein D, L, E, G, J, M, R 3 , R 4 , R 5 and R 13 are defined as in the specification, the tautomers, the enantiomers, the diastereomers, the mixtures, and the salts thereof. |